These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

938 related items for PubMed ID: 8242546

  • 41. Superior survival in treatment of primary nonmetastatic pediatric osteosarcoma of the extremity.
    Wilkins RM, Cullen JW, Odom L, Jamroz BA, Cullen PM, Fink K, Peck SD, Stevens SL, Kelly CM, Camozzi AB.
    Ann Surg Oncol; 2003 Jun; 10(5):498-507. PubMed ID: 12794015
    [Abstract] [Full Text] [Related]

  • 42. Dose-intense ifosfamide/doxorubicin/cisplatin based chemotherapy for osteosarcoma in adults.
    Patel SJ, Lynch JW, Johnson T, Carroll RR, Schumacher C, Spanier S, Scarborough M.
    Am J Clin Oncol; 2002 Oct; 25(5):489-95. PubMed ID: 12393991
    [Abstract] [Full Text] [Related]

  • 43. Relationship between dose-intensity of treatment and outcome for patients with osteosarcoma of the extremity treated with neoadjuvant chemotherapy.
    Bacci G, Ferrari S, Longhi A, Forni C, Giacomini S, Lari S, Versari M.
    Oncol Rep; 2001 Oct; 8(4):883-8. PubMed ID: 11410803
    [Abstract] [Full Text] [Related]

  • 44. Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs.
    Fuchs N, Bielack SS, Epler D, Bieling P, Delling G, Körholz D, Graf N, Heise U, Jürgens H, Kotz R, Salzer-Kuntschik M, Weinel P, Werner M, Winkler K.
    Ann Oncol; 1998 Aug; 9(8):893-9. PubMed ID: 9789613
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Effect of chemotherapy combined with caffeine for osteosarcoma.
    Tsuchiya H, Yasutake H, Yokogawa A, Baba H, Ueda Y, Tomita K.
    J Cancer Res Clin Oncol; 1992 Aug; 118(8):567-9. PubMed ID: 1517277
    [Abstract] [Full Text] [Related]

  • 54. Results of API-AI based regimen in osteosarcoma adult patients included in the French OS2006/Sarcome-09 study.
    Piperno-Neumann S, Ray-Coquard I, Occean BV, Laurence V, Cupissol D, Perrin C, Penel N, Bompas E, Rios M, Le Cesne A, Italiano A, Anract P, de Pinieux G, Collard O, Bertucci F, Duffaud F, Le Deley MC, Delaye J, Brugieres L, Blay JY.
    Int J Cancer; 2020 Jan 15; 146(2):413-423. PubMed ID: 31246277
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Neoadjuvant chemotherapy for osteosarcoma of the extremity: long-term results of the Rizzoli's 4th protocol.
    Bacci G, Briccoli A, Ferrari S, Longhi A, Mercuri M, Capanna R, Donati D, Lari S, Forni C, DePaolis M.
    Eur J Cancer; 2001 Nov 15; 37(16):2030-9. PubMed ID: 11597381
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Comparative outcome of Thai pediatric osteosarcoma treated with two protocols: the role of high-dose methotrexate (HDMTX) in a single institute experience.
    Choeyprasert W, Pakakasama S, Sirachainan N, Songdej D, Chuansumrit A, Anurathapan U, Hongeng S, Nartthanarung A.
    Asian Pac J Cancer Prev; 2014 Nov 15; 15(22):9823-9. PubMed ID: 25520112
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 47.